Citations

Clear

6 citation(s) found for "George, Susan".

Reflecting on Progress in and Establishing Benchmarks for Sex and Gender Health Education
Barr, Elizabeth , Chin, Eliza Lo, Rojek, Mary K., Sleeper, Rebecca B. , Temkin, Sarah M. , Clayton, Janine A. , Kantarci, Kejal , Kling, Juliana M. , McGregor, Alyson J. , Schiebinger, Londa , Viggiano, Thomas R., Wood, Susan F. , Werbinski, Jan, Temkin, Sarah M , Clayton, Janine A , Kantarci, Kejal , Kling, Juliana M , Schiebinger, Londa , Templeton, Kimberly , Newman, Connie B. , Templeton, Kimberly

Mayo Clinic

Academic Medicine | September 23, 2023 | Volume: 99 | Issue: 1 | Pages: 16-21

10.1097/acm.0000000000005444 | PMID 37734039 Get It

Abstract Sex and gender influence every aspect of human health; thus, sex- and gender-related topics should be incorporated in all aspects of health education curricula. Sex and gender health education (SGHE) is the rigorous, intersectional, data-driven integration of sex and gender into all elements of health education. A multisectoral group of thought leaders has collaborated to advance SGHE since 2012. This cross-sector collaboration to advance SGHE has been successful on several fronts, primarily developing robust interprofessional SGHE programs, hosting a series of international SGHE summits, developing sex- and gender-specific resources, and broadening the collaboration beyond medical education. However, other deeply entrenched challenges have proven more difficult to address, including accurate and consistent sex and gender reporting in research publications, broadening institutional support for SGHE, and the development and implementation of evaluation plans for assessing learner outcomes and the downstream effects of SGHE on patient care. This commentary reflects on progress made in SGHE over the first decade of the current collaboration (2012–2022), articulates a vision for next steps to advance SGHE, and proposes 4 benchmarks to guide the next decade of SGHE: (1) integrate sex, gender, and intersectionality across health curricula; (2) develop sex- and gender-specific resources for health professionals; (3) improve sex and gender reporting in research publications; and (4) develop evaluation plans to assess learner and patient outcomes.
Thromboelastography Parameters do not Discriminate for Thrombotic Events in Hospitalized Patients With COVID-19
Kartiko, Susan , Yamane, David , Siddique, Abu Bakkar , Levine, Andrea R. , Jackson, Amanda, Wieruszewski, Patrick M. , Smischney, Nathan J. , Chow, Jonathan H. , Investigators, for the CRUSH COVID, Levine, Andrea R , Wieruszewski, Patrick M , Smischney, Nathan J , Chow, Jonathan H , Koizumi, Naoru , Sarani, Babak , Khanna, Ashish K. , Investigators, for the CRUSH COVID

Mayo Clinic

Journal of Intensive Care Medicine | November 30, 2022 | Volume: 38 | Issue: 5 | Pages: 449-456

10.1177/08850666221142265 | PMID 36448250 Get It

Background Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic state; leading to multiple sequelae. We sought to detect whether thromboelastography (TEG) parameters would be able to detect thromboembolic events in patients hospitalized with COVID-19. Methods We performed a retrospective multicenter case–control study of the Collaborative Research to Understand the Sequelae of Harm in COVID (CRUSH COVID) registry of 8 tertiary care level hospitals in the United States (US). This registry contains adult patients with COVID-19 hospitalized between March 2020 and September 2020. Results A total of 277 hospitalized COVID-19 patients were analyzed to determine whether conventional coagulation TEG parameters were associated with venous thromboembolic (VTE) and thrombotic events during hospitalization. A clotting index (CI) >3 was present in 45.8% of the population, consistent with a hypercoagulable state. Eighty-three percent of the patients had clot lysis at 30 min (LY30) = 0, consistent with fibrinolysis shutdown, with a median of 0.1%. We did not find TEG parameters (LY30 area under the receiver operating characteristic [ROC] curve [AUC] = 0.55, 95% CI: 0.44-0.65, P value = .32; alpha angle [α] AUC = 0.58, 95% CI: 0.47-0.69, P value = .17; K time AUC = 0.58, 95% CI: 0.46-0.69, P value = .67; maximum amplitude (MA) AUC = 0.54, 95% CI: 0.44-0.64, P value = .47; reaction time [R time] AUC = 0.53, 95% CI: 0.42-0.65, P value = .70) to be a good discriminator for VTE. We also did not find TEG parameters (LY30 AUC = 0.51, 95% CI: 0.42-0.60, P value = .84; R time AUC = 0.57, 95%CI: 0.48-0.67, P value .07; α AUC = 0.59, 95%CI: 0.51-0.68, P value = .02; K time AUC = 0.62, 95% CI: 0.53-0.70, P value = .07; MA AUC = 0.65, 95% CI: 0.57-0.74, P value < .01) to be a good discriminator for thrombotic events. Conclusions In this retrospective multicenter cohort study, TEG in COVID-19 hospitalized patients may indicate a hypercoagulable state, however, its use in detecting VTE or thrombotic events is limited in this population.
Methemoglobinemia in Transplant Recipient Patients: Future of Dapsone as Pneumocystis carinii Pneumonia Prophylaxis
Sahu, Kamal Kant , Lal, Amos , George, Susan, Lal, Amos , Mishra, Ajay Kumar

Mayo Clinic

Progress in Transplantation | January 2, 2020 | Volume: 30 | Issue: 1 | Pages: 71-72

10.1177/1526924819893316 | PMID 31894730 Get It

1308: ELECTRONIC INSULIN INFUSION PROTOCOL WITH LESS FREQUENT GLUCOSE MONITORING IN THE CRITICALLY ILL
Lal, Amos , Katta, Sai , Lee, Jennifer , George, Susan, Trivedi, Nitin , Lal, Amos

Mayo Clinic

Critical Care Medicine | December 18, 2019 | Volume: 48 | Issue: 1 | Pages: 631-631

10.1097/01.ccm.0000645148.79632.fe Get It

Acetaminophen induced methemoglobinemia
Sahu, Kamal Kant , Lal, Amos , George, Susan, Lal, Amos , Mishra, Ajay Kumar

Mayo Clinic

Clinical Toxicology | October 17, 2019 | Volume: 58 | Issue: 7 | Pages: 784-785

10.1080/15563650.2019.1677909 | PMID 31621426 Get It

Embedding Concepts of Sex and Gender Health Differences into Medical Curricula
Miller, Virginia M. , Rice, Morrisa, Schiebinger, Londa , Jenkins, Marjorie , Werbinski, Janice L., Núñez, Ana E. , Wood, Susan F. , Viggiano, Thomas R., Shuster, Lynne T., Schiebinger, Londa

Mayo Clinic

Journal of Women's Health | February 15, 2013 | Volume: 22 | Issue: 3 | Pages: 194-202

10.1089/jwh.2012.4193 | PMID 23414074 Get It

Sex, a biological variable, and gender, a cultural variable, define the individual and affect all aspects of disease prevention, development, diagnosis, progression, and treatment. Sex and gender are essential elements of individualized medicine. However, medical education rarely considers such topics beyond the physiology of reproduction. To reduce health care disparities and to provide optimal, cost-effective medical care for individuals, concepts of sex and gender health need to become embedded into education and training of health professionals. In September 2012, Mayo Clinic hosted a 2-day workshop bringing together leading experts from 13 U.S. schools of medicine and schools of public health, Health Resources and Services Administration Office of Women's Health (HRSA OWH), the National Institutes of Health (NIH) Office of Research on Women's Health (ORWH), and the Canadian Institute of Health and Gender. The purpose of this workshop was to articulate the need to integrate sex- and gender-based content into medical education and training, to identify gaps in current medical curricula, to consider strategies to embed concepts of sex and gender health into health professional curricula, and to identify existing resources to facilitate and implement change. This report summarizes these proceedings, recommendations, and action items from the workshop.